| Literature DB >> 33664277 |
Claire H Masterson1,2, Arata Tabuchi3, Grace Hogan1,4, Glenn Fitzpatrick4, Steven W Kerrigan4, Mirjana Jerkic1, Wolfgang M Kuebler3,5,6, John G Laffey1,7,2,8,5,9,10, Gerard F Curley11,12,13,14.
Abstract
Mesenchymal stem/stromal cells (MSCs) have demonstrated efficacy in pre-clinical models of inflammation and tissue injury, including in models of lung injury and infection. Rolling, adhesion and transmigration of MSCs appears to play a role during MSC kinetics in the systemic vasculature. However, a large proportion of MSCs become entrapped within the lungs after intravenous administration, while the initial kinetics and the site of arrest of MSCs in the pulmonary vasculature are unknown. We examined the kinetics of intravascularly administered MSCs in the pulmonary vasculature using a microfluidic system in vitro and intra-vital microscopy of intact mouse lung. In vitro, MSCs bound to endothelium under static conditions but not under laminar flow. VCAM-1 antibodies did not affect MSC binding. Intravital microscopy demonstrated MSC arrest at pulmonary micro-vessel bifurcations due to size obstruction. Retention of MSCs in the pulmonary microvasculature was increased in Escherichia coli-infected animals. Trapped MSCs deformed over time and appeared to release microvesicles. Labelled MSCs retained therapeutic efficacy against pneumonia. Our results suggest that MSCs are physically obstructed in pulmonary vasculature and do not display properties of rolling/adhesion, while retention of MSCs in the infected lung may require receptor interaction.Entities:
Mesh:
Year: 2021 PMID: 33664277 PMCID: PMC7933415 DOI: 10.1038/s41598-021-83894-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379